期刊文献+

中年男性2型糖尿病患者胰岛素抵抗与前列腺体积的关系 被引量:3

下载PDF
导出
摘要 目的:分析在中年男性新诊断的2型糖尿病患者中,胰岛素抵抗与前列腺体积(PV)的关系。方法40-65岁男性新诊断的2型糖尿病患者共193例,非糖尿病对照组57例,均检测空腹血糖(FPG)、空腹胰岛素浓度(FINS)、糖化血红蛋白(HbA1c)、血脂系列(TC、TG、LDL、HDL)及PV等相关临床指标,计算胰岛素抵抗指数(HOMA-IR)。结果糖尿病组的PV显著高于非糖尿病组(P〈0.05),糖尿病中胰岛素抵抗组(80例)PV明显高于非胰岛素抵抗组(113例)(t=2.740,P〈0.05)。良性前列腺增生(BPH)组(131例)的HOMA-IR显著高于非BPH组(62例)(t=3.320,P〈0.05)。相关分析显示,年龄、IR与PV呈正相关(r分别为0.263、0.309;均P〈0.05)。多元逐步回归分析显示,年龄、IR为PV的独立危险因素(b值分别为4.598、4.270;均P〈0.05)。结论2型糖尿病患者胰岛素抵抗是导致前列腺体积增加的危险因素。 Objective To evaluate the relationship between insulin resistance and prostate volume(PV) in middle-aged male patients with newly diagnosed type 2 diabetes. Methods Totally 193 male patients from 40 to 65 years old and were included in this study.PV and biochemica1 analyses including fasting blood glucose,serum fasting levels of insulin(FINS),HbA1C and lipid were performed.Insulin resistance index(HOMA-IR)was calculated.Results PV was more increased in diabetes group(193cases) compared with non-diabetes group (57cases) (t=2.441,P〈0.05),and in insulin resistant group(80cases)compared with non-insulin resistant group (113cases) (t=2.740,P〈0.05).HOMA-IR was more increased in BPH group (131 cases) compared with non-BPH group(62 cases)(t=3.320,P〈0.05).PV was positively correlated with age and IR (r=0.263,0.309;P〈0.05).Age and IR were independent risk factors of PV. Conclusions Insulin resistance in type 2 diabetes.might be the risk factors of increasing of the prostate volume.
出处 《浙江临床医学》 2014年第11期1740-1742,共3页 Zhejiang Clinical Medical Journal
关键词 糖尿病 2型 胰岛素抵抗 前列腺增生 Diabetes msllitus Type2 Insuline resistance Prostatic hyperplasia
  • 相关文献

参考文献3

二级参考文献21

  • 1李培军,张祥华,郭利君,那彦群.高脂血症与良性前列腺增生相关性的临床研究[J].中华外科杂志,2005,43(6):387-389. 被引量:33
  • 2顾东风,Reynolds K,杨文杰,陈恕凤,吴锡桂,段秀芳,蒲晓东,徐丽华,吴先萍,陈祥福,魏仁敏,陈娜萦,吴天一,王礼桂,姚才良,牟建军,马义峰,王晓飞,Whelton P,何江.中国成年人代谢综合征的患病率[J].中华糖尿病杂志(1006-6187),2005,13(3):181-186. 被引量:580
  • 3Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associat-ed with benign prostatic hyperplasia [J]. J Clin Endocrinol Metab, 2006 91 (7):2562-2568.
  • 4Nandeesha H, Koner BC, Dorairajan LN, et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia[J]. Clin Chim Acta,2006, 370(1-2):89-93.
  • 5Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic hyperplasia[J]. Eur Urol, 2007, 51 ( 1 ):199-206.
  • 6Vikram A, Jena GB, Ramarao P. Insulin-resistance and benign pros- tatic hyperplasia: the connection[J]. Eur J Pharmacol, 2010,70(1): 75-81.
  • 7Kim YJ, Cho YJ, Oh JE, et al. The associaton between metabolic ayndrome and prostate-specific antigen levels[J]. Int J Urol,2008,15 (10):905-909.
  • 8Parsons JK,Carter HB,Partin AW. Metabolic factors associated with benign prostatic hyperplasia[J].Journal of Clinical Endocrinology and Metabolism,2006,(07):2562-2568.doi:10.1210/jc.2005-2799.
  • 9The International Expert Committee. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes[J].Diabetes Care,2009,(07):1327-1334.doi:10.2337/dc09-9033.
  • 10Berry SJ,Coffey DS,Walsh PC. The development of human benign prostatic hyperplasia with age[J].Journal of Urology,1984.474-479.

共引文献109

同被引文献40

  • 1徐元林,王伟.心脏缺血预处理与后处理的临床应用[J].上海交通大学学报(医学版),2011,31(9):1328-1331. 被引量:6
  • 2张祥华,王行环,王刚,魏强,许传亮,薛蔚,严维刚,杨家荣,朱刚,孙颖浩,叶章群,孙则禹,那彦群.良性前列腺增生临床诊治指南[J].中华外科杂志,2007,45(24):1704-1707. 被引量:229
  • 3SuzukiY, SlomkaPJ, WolakA, et al. Motion-frozen myocardial perfusion SPECT improves detection of coronary artery disease in obese patients[J]. J Nucl Med, 2008, 49(7):1075-1079. DOI: 10.2967/jnumed.108.050997.
  • 4SlomkaPJ, NishinaH, BermanDS, et al. " Motion-frozen" display and quantification of myocardial perfusion[J]. J Nucl Med, 2004, 45(7):1128-1134.
  • 5Le MeunierL, SlomkaPJ, DeyD, et al. Motion frozen 18F-FDG cardiac PET[J]. J Nucl Cardiol, 2011, 18(2):259-266. DOI:10.1007/s12350-010-9322-3.
  • 6SaghariM, AssadiM, EftekhariM, et al. Frequency and severity of myocardial perfusion abnormalities using 99Tcm-MIBI SPECT in cardiac syndrome X[J]. BMC Nucl Med, 2006, 6:1. DOI:10.1186/1471-2385-6-1.
  • 7BermanDS, KangX, SlomkaPJ, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease[J]. J Nucl Cardiol, 2007, 14(4):521-528. DOI:10.1016/j.nuclcard.2007.05.008.
  • 8FaberTL, SantanaCA, GarciaEV, et al. Three-dimensional fusion of coronary arteries with myocardial perfusion distributions: clinical validation[J]. J Nucl Med, 2004, 45(5):745-753.
  • 9Parsons JK, Carter HB, Partin AW, et al. Metabolic fac- tors associated with benign prostatic hyperplasia[J]. J Clin Endocrinol Meta, 2006,91 (7) : 2562-2568.
  • 10Ozden C,Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in pa- tients with benign prostatic hyperplasia[J]. Eur Urol, 2007,51(1):199-203.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部